Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
06/2002
06/05/2002CN1352632A N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor
06/05/2002CN1352631A Aromatic amides
06/05/2002CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002US6399827 Quaternary ammonium phosphate compound and method of preparing same
06/04/2002US6399824 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure
06/04/2002US6399808 Reacting amine with carbon dioxide in anhydrous solvent
06/04/2002US6399778 Crystalline solvate
06/04/2002US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives
06/04/2002US6399618 Compositions and methods for modulating sexual activity
06/04/2002US6399614 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
06/04/2002CA2364108A1 Acylamino cyclopropane derivatives
06/04/2002CA2174097C Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
05/2002
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002042254A1 PROCESS OF PRODUCING CARBONYL a-SUBSTITUTED NITROGEN-CONTAINING COMPOUNDS
05/30/2002WO2002042248A2 Naphthalene derivatives
05/30/2002WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
05/30/2002WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
05/30/2002US20020065303 Bivalent phenylene inhibitors of factor Xa
05/30/2002US20020065282 Tetralone derivatives
05/30/2002US20020065281 Compositions containing a benzamide disulfide derivative for treating allergic diseases
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives
05/30/2002US20020065251 Quaternary ammonium phosphate compound is formed by reacting quaternary ammonium hydroxide containing methylbenzene group with phosphoric acid, which acts as anticorrosive and microbiocide
05/30/2002US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis
05/30/2002US20020065228 Inhibition of biosynthesis of a digestive enzyme of blood-ingesting pests known to feed on humans and animals; insecticides; pesticides; miticides; beetles; moths; flies; fleas; mosquitoes; lice
05/30/2002US20020065192 Productivity catalysts and microstructure control
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/29/2002EP1209148A1 Process for the preparation of amine oxides
05/29/2002EP1209146A1 Process for the hydrogenation of nitriles to primary amines using Raney-catalysts
05/29/2002EP1208093A1 Cinnamic acid nitrile method of production and use thereof
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof
05/29/2002CN1085661C Piperidine derivatives as neurokinin antagonists
05/28/2002US6395916 Amine, phosphine ligands
05/28/2002US6395911 Process for cis-1{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine
05/28/2002US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease
05/28/2002US6395740 Calcitonin mimetics
05/28/2002US6395739 N-phenyl-N′-phenylpopylpiperazine derivatives and process for the preparation
05/28/2002US6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them
05/28/2002US6395735 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor
05/28/2002US6395731 Anticoagulants
05/28/2002CA2221091C Estrogen agonist/antagonists treatment of atherosclerosis
05/23/2002WO2002040602A1 Fluorinated-photoinitiators in dual cure resins
05/23/2002WO2002040466A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
05/23/2002WO2002040461A2 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications
05/23/2002WO2002039970A1 Novel coupler for use in oxidative hair dyeing
05/23/2002WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
05/23/2002WO2002004419A3 α,α-DIBROMO-α-CHLORO-ACETOPHENONES AS SYNTHONS
05/23/2002WO2001083571A3 Catalysts containing n-pyrrolyl substituted nitrogen donors
05/23/2002US20020062012 Novel azoamidine compound
05/23/2002US20020061890 Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives
05/23/2002US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis
05/23/2002US20020061879 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
05/23/2002DE10057055A1 Amino-malonic acid dinitrile preparation, for use as intermediate for soluble guanylate cyclase stimulating drugs, by reacting N,N-disubstituted iminium salt and trimethylsilyl cyanide
05/23/2002DE10056840A1 Continuous hydrogenation of nitrites to primary amines over activated Raney catalyst, involves hydrogenating nitrites in absence of ammonia and basic alkali or alkaline earth metal compounds
05/23/2002DE10056839A1 Verfahren zur Hydrierung von Nitrilen an Raney-Katalysatoren A process for hydrogenating nitrites over Raney catalysts
05/23/2002CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
05/23/2002CA2424477A1 Fluorinated-photoinitiators in dual cure resins
05/22/2002EP1207149A1 Process for the hydrogenation of nitriles on Raney catalysts
05/22/2002EP1206446A1 Carboxylic acid amides, their production and their use as drugs
05/22/2002EP1206444A1 Compounds that inhibit tryptase activity
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1350452A Preventive or therapeutic drugs for diabetes
05/21/2002US6392103 Using organometallic compound as catalyst
05/21/2002US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide
05/21/2002US6391910 Opioid antagonist; analgesic
05/21/2002US6391892 Naphthyl pharmaceutical compounds
05/21/2002US6391890 Heterocyclic compounds
05/16/2002WO2002038552A1 A novel method for the preparation of piperazine and its derivatives
05/16/2002WO2002038540A2 Activity-dependent cysteine protease profiling reagent
05/16/2002WO2002038528A1 Pleuromutilin derivatives with antimicrobial activity
05/16/2002WO2001079155A3 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
05/16/2002WO2001040219A3 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
05/16/2002US20020058842 Continuous hydrogenation of nitrites to primary amines in the liquid phase over a suspended, activated Raney catalyst based on an alloy of aluminum and at least one transition metal, in absence of ammonia
05/16/2002US20020058841 Hydrogenating nitrites to primary amines over an activated, alpha-aluminum oxide(Al2O3)-containing, macroporous Raney catalyst based on an alloy of aluminum and at least one transition metal
05/16/2002US20020058811 Naphthalene derivatives
05/16/2002US20020058710 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure
05/16/2002US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception
05/16/2002US20020058631 Dipeptide derivatives
05/16/2002US20020056827 Piezoelectric element and process for production thereof
05/16/2002DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives
05/15/2002EP1205473A1 Vesamicol piperazine derivatives and drugs containing the same
05/15/2002EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/15/2002EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof
05/15/2002EP1204592A1 Zeolite ssz-52
05/15/2002CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders
05/15/2002CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors
05/15/2002CN1349497A Monofluoroalkyl derivatives
05/15/2002CN1349496A Caspase inhibitors and the use thereof
05/15/2002CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
05/15/2002CN1084743C 毒蕈碱拮抗剂 Muscarinic antagonist
05/15/2002CN1084740C Angiogensis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
05/14/2002US6388122 Tryptase inhibitor and novel guanidino derivatives
05/14/2002US6388118 Process for the preparation of cyclopentadienyl compounds and compounds obtained therefrom
05/14/2002US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors
05/14/2002US6388076 Antiproliferative agents; skin disorders; osteoporosis
05/14/2002US6388022 Polystyrene